
Understand the 45% dementia estimate, its population-level assumptions and how to discuss risk reduction without blame or personal guarantees.

The key term is population attributable fraction, often shortened to PAF. The Commission uses this measure to describe the potential share of dementia cases linked to a group of risk factors under a modeled scenario.
An explanation of the calculation describes the question this way: how might case numbers change if exposure to the included factors were removed or reduced? The answer combines information about how common those factors are with evidence about their association with dementia.
That means the calculation has different inputs from a personal risk assessment. A common factor can matter greatly for population health because many people are exposed to it. The estimate is about the possible effect across that population.
The words potentially preventable or delayable also deserve attention. The headline combines prevention with delay. It should not be shortened to a promise that the estimated share of cases would disappear permanently.
For an individual reader, the figure does not account for their particular medical history or genetics. It also does not specify the benefit they would receive from changing a particular factor now. A population share and a personal probability answer different questions.
Keeping those questions separate is central to discussing population estimates without assigning personal responsibility. The statistic describes a possible change in case numbers, not a score for how well someone has managed their health.
The headline comes from the 2024 Commission report rather than a single prevention trial with one participant group and one follow-up period. Its scope covers risk factors across different stages of life.
The report summary does not provide a single sample size, study duration or demographic breakdown for the evidence behind the combined estimate. Those details should not be invented or replaced with the characteristics of a separate study. The life-course scope is also not the same thing as a trial that followed participants throughout their lives.
The Commission identifies these 14 factors:
The report added high LDL cholesterol and untreated vision loss to its earlier list.
For readers over 60, the life-course framing matters. The estimate is not measuring only decisions made after retirement or exposures that begin in later life. It brings together factors that can arise at different ages and under very different circumstances.
It is therefore better understood as a broad prevention framework than as the result of a program tested specifically in adults over 60.
No. The explanation of PAF calculations makes a central distinction: estimating preventable cases requires a causal interpretation of the relationship between a factor and dementia.
An association means that a factor and an outcome occur together in a pattern. A causal claim goes further. It says that changing the factor would change the outcome.
For the modeled reduction to become an observed reduction, changing exposure needs to affect dementia outcomes. It is not enough to identify different dementia rates among people with different exposures.
The approved evidence does not establish that every listed factor has equally strong causal support. Nor does it establish that changing every factor would deliver the modeled reduction under real-world conditions.
The Commission's estimate should therefore be read as potential under a set of assumptions. It is not itself a measured treatment effect from giving everyone the same intervention.
That distinction preserves the value of the research. A model can identify prevention opportunities and guide further study without serving as proof that each proposed change produces a particular clinical benefit.
Risk factors often coexist in the same people. Their separate contributions are therefore not necessarily independent. Adding individual percentages without accounting for that overlap can misrepresent the combined total.
A separate population analysis of older US adults highlighted this problem. It also reported that differences in factor definitions and study methods complicate comparisons between estimates.
That analysis described lower estimates from several population-based studies than the Commission's figure. Its abstract cautioned that methodological differences make direct comparisons difficult. Those findings are not a replacement percentage that can be applied to every country.
The useful lesson is that a PAF needs to stay attached to the population and method that produced it. A percentage without that context can sound more universal and precise than the underlying calculation supports.
The World Health Organization's dementia guidance identifies age as the strongest known risk factor. It also supports risk reduction through health behaviors and management of relevant conditions. Environmental factors matter too.
For a conversation with a healthcare professional, WHO identifies several practical areas:
These topics provide a basis for discussing present health priorities. They need not become a pass-or-fail checklist. A qualified healthcare professional can help connect them with a person's circumstances without treating a population estimate as a personal target.
For a closer examination of a specific area, FitBrainLab also reviews the research surrounding blood-pressure care and dementia rates.
WHO also states that risk reduction requires supportive systems and policies. Poverty and unequal access to education or employment shape people's circumstances. Access to health care matters too.
This puts the role of public policy in dementia risk reduction alongside individual action. Describing a factor as modifiable does not mean that every person has equal power to change it.
The practical message is to discuss opportunities for supporting health without turning an illness into evidence of personal failure.
Future clinical research should test whether changes in the listed factors lead to fewer dementia cases or later onset in real-world settings. Useful studies would clearly describe their participants and follow-up periods. They should report dementia outcomes rather than relying only on changes in risk factors. Research should also examine whether better access to care and healthier environments makes benefits more widely available. The next advance is not simply a more striking percentage. It is stronger evidence about which changes help, for whom and under what conditions.
Bringing a dementia-risk estimate into a health conversation calls for separating statistical possibilities from personal predictions, a distinction FitBrainLab addresses through research-led reporting. For adults 60+ unsettled by alarming dementia headlines, its explanations of memory and cognitive aging provide calm context without treating illness as a judgment on personal choices.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.



Build habits that support memory, focus and a curious, connected life.
Read the Blog